Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: An isobolographic analysis

Epilepsia

Volumn 47, Issue 1, 2006, Pages 10-20

  Luszczki, Jarogniew J ^a   Andres, Marta M ^b   Czuczwar, Piotr ^a   Cioczek Czuczwar, Anna ^a   Ratnaraj, Neville ^c   Patsalos, Philip N ^c   Czuczwar, Stanislaw J ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Antiepileptic drugs; Carbamazepine; Isobolographic analysis; Levetiracetam; Maximal electroshock; Oxcarbazepine; Pharmacodynamic interactions; Topiramate

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG BRAIN LEVEL; DRUG EFFECT; DRUG POTENTIATION; ELECTRIC SHOCK; LONG TERM MEMORY; MALE; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; SEIZURE; TASK PERFORMANCE;

EID: 33645019118     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2006.00364.x     Document Type: Article

References (73)

1. Cereghino JJ Biton V Abou-Khalil B et al Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial Neurology 2000 55 236 442
2. Betts T Waegemans T Crawford P A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy Seizure 2000 9 80 87
3. Grant R Shorvon SD Efficacy and tolerability of 1000-4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy Epilepsy Res 2000 42 89 95
4. Shorvon SD Lowenthal A Janz D et al Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures: European, Levetiracetam Study, Group Epilepsia 2000 41 1179 1186
5. Kumar SP Smith PE Levetiracetam as add-on therapy in generalised epilepsies Seizure 2004 13 475 477
6. Greenhill L Betts T Smith K Effect of levetiracetam on resistant juvenile myoclonic epilepsy [Abstract] Epilepsia 2001 42 suppl 7 179
7. Krauss GL Betts T Abou-Khalil B et al Levetiracetam treatment of idiopathic generalised epilepsy Seizure 2003 12 617 620
8. Genton P Gelisse P Antimyoclonic effect of levetiracetam Epileptic Disord 2000 2 209 212
9. Frucht SJ Louis ED Chuang C et al A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus Neurology 2001 57 1112 1114
10. Kasteleijn-Nolst Trenite DG Marescaux C Stodieck S et al Photosensitive epilepsy: a model to study the effects of antiepileptic drugs: evaluation of the piracetam analogue, levetiracetam Epilepsy Res 1996 25 225 230
11. Bourgeois BFD Holder DL Valencia I et al Open-label assessment of levetiracetam efficacy and adverse effects in a pediatric population [Abstract] Epilepsia 2001 42 suppl 7 53 54
12. Tan MJ Appleton RE Efficacy and tolerability of levetiracetam in children aged 10 years and younger: a clinical experience Seizure 2004 13 142 145
13. Ben-Menachem E Falter U Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy: European, Levetiracetam Study, Group Epilepsia 2000 41 1276 1283
14. Alsaadi TM Koopmans S Apperson M et al Levetiracetam monotherapy for elderly patients with epilepsy Seizure 2004 13 58 60
15. Alsaadi TM Thieman C Zusman EE Levetiracetam monotherapy for adults with localization-related epilepsy Epilepsy Behav 2002 3 471 474
16. Alsaadi TM Thieman C Levetiracetam monotherapy for newly diagnosed epilepsy patients Seizure 2003 12 154 156
17. Madeja M Margineanu DG Gorji A et al Reduction of voltage-operated potassium currents by levetiracetam: a novel antiepileptic mechanism of action? Neuropharmacology 2003 45 661 671
18. Lukyanetz EA Shkryl VM Kostyuk PG Selective blockade of N-type calcium channels by levetiracetam Epilepsia 2002 43 9 18
19. Niespodziany I Klitgaard H Margineanu DG Levetiracetam inhibits the high-voltage-activated Ca(2+) current in pyramidal neurones of rat hippocampal slices Neurosci, Lett 2001 306 5 8
20. Pisani A Bonsi P Martella G et al Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine Epilepsia 2004 45 719 728
21. Zona C Niespodziany I Marchetti C et al Levetiracetam does not modulate neuronal voltage-gated Na+ and T-type, Ca2+ currents Seizure 2001 10 279 286
22. Rigo JM Hans G Nguyen L et al The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents Br J Pharmacol 2002 136 659 672
23. Lynch BA Lambeng N Nocka K et al The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam Proc, Natl Acad, Sci U S A 2004 101 9861 9866
24. Löscher W Honack D Rundfeldt C Antiepileptic effects of the novel anticonvulsant levetiracetam (ucb LO59) in the kndling model of temporal epilepsy J Pharmacol Exp Ther 1998 285 474 479
25. Löscher W Schmidt D Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations Epilepsy Res 1988 2 145 181
26. Gower AJ Hirsch E Boehrer A et al Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy Epilepsy Res 1995 22 207 213
27. Gower AJ Noyer M Verloes R et al Ucb L059, a novel anti-convulsant drug: pharmacological profile in animals Eur J Pharmacol 1992 222 193 203 Erratum published in: Eur J Pharmacol 1993;230:389
28. Klitgaard H Matagne A Gobert J et al Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy Eur J Pharmacol 1998 353 191 206
29. Löscher W Hönack D Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats Eur J Pharmacol 1993 232 147 158
30. Patsalos PN Levetiracetam: pharmacology and therapeutics in the treatment of epilepsy and other neurological conditions Rev Contemp Pharmacother 2004 13 1 168
31. Kwan P Brodie MJ Epilepsy after the first drug fails: substitution or add-on? Seizure 2000 9 464 468
32. Kwan P Brodie MJ Early identification of refractory epilepsy N Engl J Med 2000 342 314 319
33. Perucca E Pharmacological principles as a basis for polytherapy Acta Neurol Scand Suppl 1995 162 31 34
34. Genton P Roger J Antiepileptic drug monotherapy versus polytherapy: a historical prospective Epilepsia 1997 38 suppl 5 S2 S5
35. Patsalos PN Perucca E Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs Lancet Neurol 2003 2 347 356
36. Patsalos PN Perucca E Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs Lancet Neurol 2003 2 473 481
37. Patsalos PN Fröscher W Pisani F et al The importance of drug interactions in epilepsy therapy Epilepsia 2002 43 365 385
38. Deckers CLP Czuczwar SJ Hekster YA et al Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed Epilepsia 2000 41 1364 1374
39. Stephen LJ Brodie MJ Seizure-freedom with more than one antiepileptic drug Seizure 2002 11 349 351
40. Luszczki JJ Ratnaraj N Patsalos PN et al Pharmacodynamic and pharmacokinetic interaction studies of loreclezole and felbamate, lamotrigine, topiramate and oxcarbazepine in the mouse maximal electroshock seizure model Epilepsia 2005 46 344 355
41. Sills GJ Butler E Thompson GG et al Pharmacodynamic interaction studies with topiramate in the pentylenetetrazol and maximal electroshock seizure models Seizure 2004 13 287 295
42. Mazarati AM Baldwin R Klitgaard H et al Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus Epilepsy Res 2004 58 167 174
43. Sisodiya SM Sander JW Patsalos PN Carbamazepine toxicity during combination therapy with levetiracetam: a pharmacodynamic interaction Epilepsy Res 2002 48 217 219
44. Glauser TA Pellock JM Bebin EM et al Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial Epilepsia 2002 43 518 524
45. Luszczki JJ Borowicz KK Swiader M et al Interactions between oxcarbazepine and conventional antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis Epilepsia 2003 44 489 499
46. Luszczki JJ Czuczwar M Kis J et al Interactions of lamotrigine with topiramate and first-generation antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis Epilepsia 2003 44 1003 1013
47. Luszczki JJ Czuczwar SJ Preclinical profile of combinations of some second-generation antiepileptic drugs: an isobolographic analysis Epilepsia 2004 45 895 907
48. Luszczki JJ Czuczwar SJ Isobolographic and subthreshold methods in the detection of interactions between oxcarbazepine and conventional antiepileptics: a comparative study Epilepsy Res 2003 56 27 42
49. Litchfield JT Wilcoxon F A simplified method of evaluating dose-effect experiments J Pharmacol Exp Ther 1949 96 99 113
50. Luszczki J Swiader M Czuczwar M et al Interactions of tiagabine with some antiepileptics in the maximal electroshock in mice Pharmacol Biochem Behav 2003 75 319 327
51. Porreca F Jiang Q Tallarida RJ Modulation of morphine antinociception by peripheral [Leu5]enkephalin: a synergistic interaction Eur J Pharmacol 1990 179 463 468
52. Borowicz KK Swiader M Luszczki J et al Effect of gabapentin on the anticonvulsant activity of antiepileptic drugs against electroconvulsions in mice: an isobolographic analysis Epilepsia 2002 43 956 963
53. Loewe S The problem of synergism and antagonism of combined drugs Arzneimittelforschung 1953 3 285 290
54. Berenbaum MC What is synergy? Pharmacol Rev 1989 41 93 141
55. Tallarida RJ Drug Synergism and Dose-effect Data Analysis Boca Raton Chapman & Hall/CRC 2000
56. Bourgeois BFD Wad N Combined administration of carbamazepine and phenobarbital: effect on anticonvulsant activity and neurotoxicity Epilepsia 1988 29 482 487
57. Luszczki JJ Czuczwar SJ Isobolographic profile of interactions between tiagabine and gabapentin: a preclinical study Naunyn Schmiedebergs Arch Pharmacol 2004 369 434 446
58. Ratnaraj N Doheny HC Patsalos PN A micromethod for the determination of the new antiepileptic drug levetiracetam (UCB LO59) in serum or plasma by high performance liquid chromatography Ther Drug Monit 1996 18 157 164
59. Boissier JR Tardy J Diverres JC Une nouvelle méthode simple pour explorer l'action tranquilisante: le test de la cheminée Med Exp (Basel) 1960 3 81 84
60. Venault P Chapouthier G de Carvalho LP et al Benzodiazepines impair and beta-carbolines enhance performance in learning and memory tasks Nature 1986 321 864 866
61. Luszczki JJ Swiader M Parada-Turska J et al Tiagabine synergistically interacts with gabapentin in the electroconvulsive threshold test in mice Neuropsychopharmacology 2003 28 1817 1830
62. Luszczki JJ Wojcik-Cwikla J Andres MM et al Pharmacological and behavioral characteristics of interactions between vigabatrin and conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis Neuropsychopharmacology 2005 30 958 973
63. Shank RP Gardocki IF Streeter AJ et al An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanisms of action Epilepsia 2000 41 suppl 1 S3 S9
64. Gibbs JW 3rd. Sombati S DeLorenzo RJ et al Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons Epilepsia 2000 41 suppl 1 S10 S16
65. Skradski S White HS Topiramate blocks kainate-evoked cobalt influx into cultured neurons Epilepsia 2000 41 suppl 1 S45 S47
66. Zhang X Velumian AA Jones OT et al Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate Epilepsia 2000 41 suppl 1 S52 S60
67. Luszczki JJ Andres MM Czuczwar P et al Levetiracetam selectively psychopotentiates the acute neurotoxic effects of topiramate and carbamazepine in the rotarod test in mice Eur Neuropharmacol 2005 15 609 616
68. Schmidt D Elger CE What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs? Epilepsy Behav 2004 5 627 635
69. Kelly K Stephen LJ Brodie MJ Levetiracetam for people with mental retardation and refractory epilepsy Epilepsy Behav 2004 5 878 883
70. Patsalos PN Pharmacokinetic profile of levetiracetam: toward ideal characteristics Pharmacol Ther 2000 85 77 85
71. Patsalos PN Clinical pharmacokinetics of levetiracetam Clin Pharmacokinet 2004 43 707 724
72. Perucca E Gidal BE Baltes E Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials Epilepsy Res 2003 53 47 56
73. May TW Rambeck B Jurgens U Serum concentrations of levetiracetam in epileptic patients: the influence of dose and co-medication Ther Drug Monit 2003 25 690 699